Direkt zum Inhalt
Merck

M9292

Sigma-Aldrich

Memantin -hydrochlorid

≥98% (GC), powder, NMDA glutamate receptor antagonist

Synonym(e):

3,5-Dimethyl-1-adamantanamin -hydrochlorid, 3,5-Dimethyl-amantadin -hydrochlorid, 3,5-Dimethyltricyclo[3.3.1.13,7]decan-1-amin -hydrochlorid

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

25 MG
CHF 79.10
100 MG
CHF 222.00

CHF 79.10


Voraussichtliches Versanddatum29. März 2025


Bulk-Bestellung anfordern

Größe auswählen

Ansicht ändern
25 MG
CHF 79.10
100 MG
CHF 222.00

About This Item

Empirische Formel (Hill-System):
C12H21N · HCl
CAS-Nummer:
Molekulargewicht:
215.76
EG-Nummer:
MDL-Nummer:
UNSPSC-Code:
12352200
PubChem Substanz-ID:
NACRES:
NA.77

CHF 79.10


Voraussichtliches Versanddatum29. März 2025


Bulk-Bestellung anfordern

Produktbezeichnung

Memantin -hydrochlorid, ≥98% (GC)

Qualitätsniveau

Assay

≥98% (GC)

Form

powder

Ersteller

Forest Labs

SMILES String

Cl.C[C@]12CC3C[C@](C)(C1)CC(N)(C3)C2

InChI

1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H/t9-,10+,11-,12-;

InChIKey

LDDHMLJTFXJGPI-VXMZOEJHSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Anwendung

Memantine hydrochloride has been used:
  • as a media supplement to serve as a control to study the neuroprotective effects of erythropoietin in N-methyl-D-aspartate receptor-induced toxicity[1]
  • to intraperitoneally inject experimental animal to study its effect on traumatic injury[2]
  • as a test compound to determine the dynamic range and selectivity of retinal pigment epithelium tissue penetration[3]

Biochem./physiol. Wirkung

Low-affinity NMDA glutamate receptor antagonist; stimulates dopamine release.
Memantine is effective against Alzheimer′s disease and Parkinson′s disease. It is also useful in treating epilepsy, motor neurone disease and trauma.[4]

Leistungsmerkmale und Vorteile

This compound is a featured product for ADME Tox and Neuroscience research. Discover more featured ADME Tox and Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Forest Labs. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

M Weller et al.
Brain research, 613(1), 143-148 (1993-06-04)
Effects of amantadine and memantine on NMDA receptor-mediated glutamate toxicity were studied in cultured cerebellar, cortical and mesencephalic neurons. Both drugs protected cerebellar and cortical neurons against glutamate toxicity, memantine being consistently more effective than amantadine but less effective than
C G Parsons et al.
Neuropharmacology, 32(12), 1337-1350 (1993-12-01)
Memantine (1-amino-3,5-dimethyladamantan) was tested as an antagonist of N-methyl-D-aspartate (NMDA) receptors on cultured superior collicular and hippocampal neurones using the patch clamp technique and its actions were compared to those of Mg2+ ions, ketamine, dextrorphan, dextromethorphan, phencyclidine and dizocilpine (MK-801).
Anton N Shuvaev et al.
International journal of molecular sciences, 22(15) (2021-08-08)
Spinocerebellar ataxias are a family of fatal inherited diseases affecting the brain. Although specific mutated proteins are different, they may have a common pathogenetic mechanism, such as insufficient glutamate clearance. This function fails in reactive glia, leading to excitotoxicity and
Anton N Shuvaev et al.
Brain sciences, 12(4) (2022-04-22)
Memantine is an FDA approved drug for the treatment of Alzheimer's disease. It reduces neurodegeneration in the hippocampus and cerebral cortex through the inhibition of extrasynaptic NMDA receptors in patients and mouse models. Potentially, it could prevent neurodegeneration in other
Dementia of Alzheimer?s disease and other neurodegenerative disorders-memantine, a new hope
Sonkusare SK, et al.
Pharmacological Research, 51(1), 1-17 (2005)

Artikel

Discover Bioactive Small Molecules for ADME/Tox

DISCOVER Bioactive Small Molecules for Neuroscience

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.